Is carboplatin plus taxol an effective third-line regimen in recurrent undifferentiated nasopharyngeal carcinoma?
The combination has a good palliative role as third-line chemotherapy in recurrent undifferentiated nasopharyngeal cancer.
This is the first study showing that blood-based self-testing with current technology is feasible in HIV-negative participants demanding the test and without prior training or supervision. Bearing in mind that it was conducted under difficult weather conditions and using a complex kit, over-the-counter tests could be a feasible option to complement current diagnostic strategies. More studies are needed to accommodate technology, minimise interpretation mistakes and provide on-line support.